AC Immune SA (DE:IMR)
FRANKFURT:IMR
Holding DE:IMR?
Track your performance easily

AC Immune SA (IMR) Income Statement

0 Followers

AC Immune SA Income Statement

Last quarter (Q4 2023), AC Immune SA's total revenue was CHF―, a decrease of ― from the same quarter last year. In Q4, AC Immune SA's net income was CHF―. See AC Immune SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
CHF 3.93MCHF 14.80MCHF 3.94M-CHF 15.43MCHF 110.46M
Cost of Revenue
--CHF -74.78M---
Gross Profit
-CHF 14.80MCHF 3.94M---
Operating Expense
CHF 37.26MCHF 68.60MCHF 76.10MCHF 80.20MCHF 76.69MCHF 65.92M
Operating Income
CHF -33.32MCHF -53.80MCHF -72.17MCHF -80.20MCHF -61.26MCHF 44.54M
Net Non Operating Interest Income Expense
CHF -192.00KCHF 1.04MCHF 69.00KCHF 6.50MCHF -106.00KCHF -1.62M
Other Income Expense
CHF 362.00K-CHF -1.34MCHF -601.00KCHF -555.00KCHF 2.53M
Pretax Income
CHF -33.15MCHF -54.22MCHF -70.74MCHF -72.99MCHF -61.92MCHF 45.44M
Tax Provision
CHF 7.00KCHF 10.00KCHF 13.00KCHF 3.00KCHF 0.00CHF 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
CHF -33.16MCHF -54.23MCHF -70.73MCHF -72.99MCHF -61.92MCHF 45.44M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
CHF 37.26MCHF 68.60MCHF 1.32MCHF 80.20MCHF 76.69MCHF 65.92M
Net Income From Continuing And Discontinued Operation
CHF -33.16MCHF -54.23MCHF -70.73MCHF -72.99MCHF -61.92MCHF 45.44M
Normalized Income
CHF -33.38M---CHF -61.37MCHF 42.91M
Interest Expense
CHF 203.00K---CHF 184.00KCHF 1.93M
EBIT
CHF -32.95M-CHF -70.74MCHF -72.99MCHF -61.74MCHF 47.37M
EBITDA
CHF -31.80M-CHF -68.95MCHF -71.10MCHF -59.77MCHF 49.06M
Currency in CHF

AC Immune SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis